MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/12034754231191509

Медицинская библиотека · Journal of cutaneous medicine and surgery · 2023

Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Gooderham Melinda J, Bissonnette Robert, Kalia Sunil, Papp Kim A, Guenther Lyn C, Gulliver Wayne P, Ho Vincent, Shear Neil H, Vender Ron, Gniadecki Robert, Prajapati Vimal H, Turchin Irina, Langholff Wayne, Parnell Kim, Simpson Scott D, Abbarin Nastaran, Lakhani Omair, Alhusayen Raed

СтатьяПеревод в очереди

Аннотация

BACKGROUND

The Psoriasis Longitudinal Assessment and Registry (PSOLAR) is a global, prospective, longitudinal, disease-based registry. It serves as a post-marketing safety commitment with a focus on patients with moderate to severe plaque psoriasis who are candidates for systemic therapy.

OBJECTIVES

To describe the baseline disease demographics and clinical characteristics of a Canadian subgroup of participants enrolled in PSOLAR.

METHODS

Baseline demographic/disease characteristics, medical histories, and previous psoriasis treatments for Canadian patients in PSOLAR were summarized using descriptive statistics.

RESULTS

There were 1896 patients analyzed in the Canadian subgroup at 37 clinical sites, accounting for 15.7% of the global PSOLAR population. Baseline disease and clinical characteristics were as expected for a moderate to severe psoriasis population and were generally similar to the global PSOLAR population. Two distinctions were noted in the Canadian subgroup versus those enrolled globally: a higher proportion of patients were overweight/obese (84.7% vs. 80.4%) and male (61.4% vs. 54.7%). In addition, the Canadian subgroup had numerically higher historical peak disease activity (PGA score 3.35 vs. 3.1) and longer disease duration (22.3 years vs. 17.5 years). Canadian PSOLAR patients reported a variety of comorbidities, including psoriatic arthritis (31.5%), hypertension (34.6%), hyperlipidemia (24.3%), mental illness (24.1%), and inflammatory bowel disease (1.6%).

CONCLUSION

The Canadian subgroup of PSOLAR patients was generally similar to those enrolled globally with respect to baseline disease demographics and clinical characteristics. Multiple comorbidities are noted in the Canadian subgroup, underscoring the need for a holistic approach to the treatment of psoriatic patients.

Для цитирования: Gooderham Melinda J, Bissonnette Robert, Kalia Sunil, Papp Kim A, Guenther Lyn C, Gulliver Wayne P, Ho Vincent, Shear Neil H, Vender Ron, Gniadecki Robert, Prajapati Vimal H, Turchin Irina, Langholff Wayne, Parnell Kim, Simpson Scott D, Abbarin Nastaran, Lakhani Omair, Alhusayen Raed. Baseline Characteristics of Canadian Patients in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).. Journal of cutaneous medicine and surgery. 2023. DOI: 10.1177/12034754231191509.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.